+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Wound Care Market by Product (Foams, Hydrocolloids, Alginates, Antimicrobial Dressings, Assessment, NPWT Devices, Substitutes, Sutures, Staples, Tapes), Wound (Surgical, Trauma, Diabetic Ulcers, Burns), End-User, Region - Global Forecast to 2024

  • ID: 4846314
  • Report
  • Region: Global
  • 304 Pages
  • Markets and Markets
1 of 5
The Global Wound Care Market is Projected to Reach USD 24.8 Billion by 2024 from USD 19.8 Billion in 2019, Growing at a CAGR of 4.6% from 2019 to 2024.

FEATURED COMPANIES

  • 3M Company
  • Acelity L.P. Inc.
  • Baxter International Inc.
  • Coloplast A/S
  • Convatec Group PLC
  • Medtronic PLC
  • MORE

The growth of the industry is driven primarily by factors such as rising incidences of road accidents & injuries, growing use of regenerative medicine, and increasing prevalence of conditions that impair wound healing capabilities. Increasing research in the field of advanced wound care and the growing popularity of active wound care products will further provide opportunities in the wound care industry. Developing economies are expected to offer a wide range of growth opportunities for players in the market.

Advanced wound care products accounted for a significant share of the market in 2019

Based on the product, the wound care market is segmented into advanced wound care, surgical wound care, and traditional wound care products. Advanced wound care products are anticipated to be the fastest-growing segment due to the rising incidence of hard-to-heal wounds and their growing adoption (due to their high efficacy).

Diabetic foot ulcers segment accounted for the largest share of the wound care market in 2019

Based on wound type, the wound care market is segmented into diabetic foot ulcers, pressure ulcers, surgical & traumatic wounds, venous leg ulcers, burns, and other wounds. Of these, the diabetic foot ulcers segment is expected to account for the largest share of the wound care market due to increased emphasis on aggressive management to prevent diabetic foot ulceration and foot amputation, using advanced and active wound care products.

Home settings segment accounted for the highest CAGR of the wound care market in 2019

Based on end-user, the wound care market is categorized into hospitals & clinics, long-term care facilities, and home care settings. Of all these end-user segments, home settings will grow at the fastest CAGR in the wound care market in 2019. The high growth of the home care settings segment is attributed to the growing incidence of chronic diseases and the rising need for comfortable and convenient care services among the rapidly growing geriatric population worldwide.

North America dominated the wound care market in 2019

North America, which includes the US, and Canada, accounted for the largest share of the wound care market. The rising incidence of diabetes, growing geriatric population, the presence of major manufacturers in the region, and easy access & rapid adoption of advanced products and technologies are driving the growth of this region

Breakdown of supply-side primary interviews, by company type, designation, and region:

  • By Company Type: Tier 1 (20%) , Tier 2 (45%), and Tier 3 (35%)
  • By Designation: C-level (30%), Director-level (20%), and Others (50%)
  • By Region: North America (35%), Europe (24%), Asia Pacific (25%), and RoW (16%)

The key players operating in this market include Smith & Nephew plc (UK), Acelity L.P. Inc. (US), Mölnlycke Health Care AB (Subsidiary of Investor AB) (Sweden), Ethicon, Inc. (A Subsidiary of Johnson & Johnson ) (US), Convatec Group Plc (UK), Baxter International Inc. (US), Coloplast A/S (Denmark), Paul Hartmann AG (Germany), Medtronic plc (Ireland), 3M Company (US), Integra LifeSciences Holding Corporation (US), Mimedx Group (US), Lohmann & Rauscher International GmbH & Co. KG (Germany), DeRoyal Industries, Inc. (US), Organogenesis Holdings Inc. (US), Kerecis (Iceland), ACell (US), IonMed (Israel), Talley Group Ltd (UK), Medela AG (Switzerland).Product launches, expansions, agreements, and acquisitions are the key growth strategies followed by most players in this market.

Research Coverage

This report studies the wound care market based on the product, wound type, end-user, and region. The report also analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micro-markets with respect to their growth trends, prospects, and contributions to the total wound care market. The report forecasts the revenue of the market segments with respect to four major regions.

Reasons to Buy the Report:

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the wound care products offered by the key 20 players in the wound care market. The report analyzes the wound care market by product, wound type, end-user, and region.
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various wound care products, their adoption, type of applications across key geographic regions.
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the wound care market
  • Competitive Assessment: In-depth assessment of market shares and strategies of the leading players in the wound care market along with a competitive leadership mapping of up to 25 players in the market and 15 Start-Ups in the market.
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • 3M Company
  • Acelity L.P. Inc.
  • Baxter International Inc.
  • Coloplast A/S
  • Convatec Group PLC
  • Medtronic PLC
  • MORE

1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology
2.1 Secondary Data
2.1.1 Key Data Points Taken From Secondary Sources
2.2 Primary Data
2.2.1 Key Data Points Taken From Primary Sources
2.2.2 Key Industry Insights
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
2.4 Market Breakdown and Data Triangulation
2.5 Assumptions for the Study

3 Executive Summary

4 Premium Insights

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.2 Restraints
5.2.3 Opportunities
5.2.4 Challenges
5.3 Regulatory Pathway for Wound Care Products
5.4 Innovations

6 Wound Care Market, By Product
6.1 Introduction
6.2 Advanced Wound Management Products
6.2.1 Advanced Wound Dressings
6.2.1.1 Foam Dressings
6.2.1.2 HyDROColloid Dressings
6.2.1.3 Film Dressings
6.2.1.4 Alginate Dressings
6.2.1.5 Hydrogel Dressings
6.2.1.6 Collagen Dressings
6.2.1.7 Other Advanced Dressings
6.2.2 Wound Therapy Devices
6.2.2.1 Pressure Relief Devices
6.2.2.2 Negative Pressure Wound Therapy (NPWT) Systems
6.2.2.2.1 Conventional NPWT Systems
6.2.2.2.2 Disposable NPWT Systems
6.2.2.3 Oxygen and Hyperbaric Oxygen Equipment
6.2.2.4 Electrical Stimulation Devices
6.2.2.5 Other Therapy Devices
6.2.3 Active Products
6.2.3.1 Biological Skin Substitutes
6.2.3.1.1 Human Donor Tissue-Derived Products
6.2.3.1.2 Acellular Animal-Derived Products
6.2.3.1.3 Biosynthetic Products
6.2.3.2 Topical Agents
6.3 Surgical Products
6.3.1 Sutures
6.3.1.1 Absorbable Sutures
6.3.1.2 Non-Absorbable Sutures
6.3.2 Staplers
6.3.2.1 Manual Surgical Staplers
6.3.2.2 Powered Surgical Staplers
6.3.3 Tissue Adhesives, Sealants, and Glues
6.3.3.1 Fibrin-Based Sealants
6.3.3.2 Collagen-Based Sealants
6.3.3.3 Synthetic Adhesives/Glues
6.3.4 Anti-Infective Dressings
6.4 Traditional Products
6.4.1 Medical Tapes
6.4.2 Dressings
6.4.3 Cleansing Agents

7 Wound Care Market, By Type
7.1 Introduction
7.2 Chronic Wounds
7.3 Acute Wounds

8 Wound Care Market, By Condition
8.1 Introduction
8.2 Surgical & Traumatic Wounds
8.3 Burns
8.4 Ulcers
8.4.1 Diabetic Foot Ulcers (DFUS)
8.4.2 Pressure Ulcers
8.4.3 Venous Leg Ulcers
8.5 Other Disease Conditions

9 Wound Care Market, By End User
9.1 Introduction
9.2 Hospitals & Specialty Clinics
9.2.1 Inpatient Settings
9.2.2 Outpatient Settings
9.3 Long-Term Care Facilities
9.4 Home Healthcare

10 Wound Care Market, By Region
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 France
10.3.3 UK
10.3.4 Italy
10.3.5 Spain
10.3.6 Russia
10.3.7 Rest of Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 Singapore
10.4.6 South Korea
10.4.7 Rest of Asia Pacific
10.5 Rest of the World
10.5.1 Latam
10.5.1.1 Brazil
10.5.1.2 Mexico
10.5.1.3 Rest of Latin America
10.5.2 Middle East & Africa

11 Competitive Landscape
11.1 Introduction
11.2 Market Share Analysis
11.3 Competitive Scenario
11.4 Competitive Leadership Mapping (2018)
11.4.1 Visionary Leaders
11.4.2 Innovators
11.4.3 Dynamic Differentiators
11.4.4 Emerging Companies
11.5 Competitive Leadership Mapping for Start-Ups (2018)
11.5.1 Progressive Companies
11.5.2 Starting Blocks
11.5.3 Responsive Companies
11.5.4 Dynamic Companies

12 Company Profiles
Business Overview, Financials, Products & Services, Developments, Author's View
12.1 Smith & Nephew PLC
12.2 Mölnlycke Health Care AB (A Subsidiary of Investor AB)
12.3 Acelity L.P. Inc.
12.4 Convatec Group PLC
12.5 Ethicon Inc. (Subsidiary of Johnson & Johnson)
12.6 Baxter International Inc.
12.7 Coloplast A/S
12.8 Medtronic PLC
12.9 3M Company
12.10 Integra Lifesciences Holdings Corporation

13 Appendix

Note:

1 The Market Size Will Be Given in Terms of Value (USD Million). Historical Year Considered for the Study Will Be 2017, With Base Year as 2018, Estimated Year as 2019 and Forecast Period Will Be 2019-2024.
2 Only 10 Leading Vendors in the Market to Be Profiled. List of Companies is Subject to Change During the Course of the Study.
3 The Market Segmentation is Subject to Revise During the Course of the Study.
4 Details on Financials Might Not Be Captured in Case of Unlisted Companies.
5 This Study Will Take 8±1 Week to Complete After Confirmation of Order.

Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • 3M Company
  • Acelity L.P. Inc.
  • Baxter International Inc.
  • Coloplast A/S
  • Convatec Group PLC
  • Ethicon Inc. (Subsidiary of Johnson & Johnson)
  • Integra Lifesciences Holdings Corporation
  • Medtronic PLC
  • Mölnlycke Health Care AB (A Subsidiary of Investor AB)
  • Smith & Nephew PLC
Note: Product cover images may vary from those shown
5 of 5

Loading
LOADING...

Adroll
adroll